Literature DB >> 25457107

The essential of 2012 results from the French Renal Epidemiology and Information Network (REIN) ESRD registry.

Mathilde Lassalle1, Carole Ayav2, Luc Frimat2, Christian Jacquelinet3, Cécile Couchoud3.   

Abstract

The French Renal Epidemiology and Information Network (REIN) registry began in 2002 to provide a tool for public health decision support, evaluation and research related to renal replacement therapies (RRT) for end-stage renal disease (ESRD). It is relying on a network of nephrologists, epidemiologists, patients and public health representatives. Continuous registration covers all dialysis and transplanted patients. In 2012, in France, 10,048 patients started a RRT (154 per million inhabitants). Elders provided majority of new patients (median age at RRT start: 70 years old). New patients had a high and age increasing rate of comorbidities, especially diabetes (42% of the new patients) and cardiovascular comorbidities (>50% of the new patients). Like previous years, incidence is stabilized. On December 31, 2012, 73,491 patients were receiving a RRT in France (1127 per million inhabitants, 56% on dialysis and 44% living with a functional renal transplant). More than 50% of patients were undergoing in-center hemodialysis with significant variations among regions. An increase in medical satellite unit hemodialysis but a decrease in self-care unit hemodialysis rates were noticed across the time, whereas peritoneal dialysis remained stable at 7%. Five years after starting RRT, the overall survival rate was 51% but only 16% among patients over 85 years. Mortality rate was highly dependent on treatment and age; transplanted patients aged 60-69 had a 27/1000 patients-year mortality rate versus 133 for a dialysis patient. Patients who started dialysis had a probability of first wait-listing of 4.8% at the start of dialysis (pre-emptive registrations) and 27% at 72 months. Whatever their diabetes status was, patients older than 60 had poor access to the waiting list. Seventeen percent of the patients received a first renal transplant within 15.4 month median time; 3% had received a pre-emptive graft. Ten years after the start of the French ESRD registry, this report provides a comprehensive and nation-wide overview of dialysis and transplantation cares in France, including overseas.
Copyright © 2014 Association Société de néphrologie. Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  ESRD; Epidemiology; Incidence; Prevalence; Survival; Transplantation

Mesh:

Year:  2014        PMID: 25457107     DOI: 10.1016/j.nephro.2014.08.002

Source DB:  PubMed          Journal:  Nephrol Ther        ISSN: 1769-7255            Impact factor:   0.722


  8 in total

1.  French patients on daily hemodialysis: clinical characteristics and treatment trajectories.

Authors:  Adélaïde Pladys; Sahar Bayat; Anne Kolko; Clémence Béchade; Cécile Couchoud; Cécile Vigneau
Journal:  BMC Nephrol       Date:  2016-07-29       Impact factor: 2.388

Review 2.  Outcome of polycystic kidney disease patients on peritoneal dialysis: Systematic review of literature and meta-analysis.

Authors:  Vincent Dupont; Lukshe Kanagaratnam; Mickaël Sigogne; Clémence Bechade; Thierry Lobbedez; Jose Portoles; Philippe Rieu; Moustapha Drame; Fatouma Touré
Journal:  PLoS One       Date:  2018-05-22       Impact factor: 3.240

3.  Fine-scale geographic variations of rates of renal replacement therapy in northeastern France: Association with the socioeconomic context and accessibility to care.

Authors:  Maxime Desmarets; Carole Ayav; Kadiatou Diallo; Florian Bayer; Frédéric Imbert; Erik André Sauleau; Elisabeth Monnet
Journal:  PLoS One       Date:  2020-07-28       Impact factor: 3.240

4.  Autodialysis in Morocco: how much longer can we wait?

Authors:  Béfa Noto-Kadou-Kaza; Hissein Ali Mahamat; Naoufal Mtioui; Amina Izem; Lalla Meryam Abouamrane; Selma El-Khayat; Mohamed Zamd; Ghislaine Medkouri; Mohamed Gharbi Benghanem; Benyounes Ramdani
Journal:  Pan Afr Med J       Date:  2019-07-03

5.  Factors associated with parathyroid hormone control in haemodialysis patients with secondary hyperparathyroidism treated with cinacalcet in real-world clinical practice: Mimosa study.

Authors:  Jacques Rottembourg; Pablo Ureña-Torres; Daniel Toledano; Victor Gueutin; Abdelaziz Hamani; Olivier Coldefy; Hedia Hebibi; Thomas Guincestre; Corinne Emery
Journal:  Clin Kidney J       Date:  2019-03-18

6.  Th17-Immune Response in Patients With Membranous Nephropathy Is Associated With Thrombosis and Relapses.

Authors:  Marion Cremoni; Vesna Brglez; Sandra Perez; Fabrice Decoupigny; Kévin Zorzi; Marine Andreani; Alexandre Gérard; Sonia Boyer-Suavet; Caroline Ruetsch; Sylvia Benzaken; Vincent Esnault; Barbara Seitz-Polski
Journal:  Front Immunol       Date:  2020-11-26       Impact factor: 7.561

7.  Blood pressure and proteinuria control remains a challenge in patients with type 2 diabetes mellitus and chronic kidney disease: experience from the prospective observational ALICE-PROTECT study.

Authors:  Jean-Michel Halimi; Dominique Joly; Christian Combe; Gabriel Choukroun; Bertrand Dussol; Jean-Pierre Fauvel; Stéphane Quéré; Béatrice Fiquet
Journal:  BMC Nephrol       Date:  2016-09-21       Impact factor: 2.388

8.  Acute saccharin infusion has no effect on renal glucose handling in normal rats in vivo.

Authors:  Grégory Jacquillet; Edward S Debnam; Robert J Unwin; Joanne Marks
Journal:  Physiol Rep       Date:  2018-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.